Underlying Molecular Mechanisms of Gliogenesis and Gliomagenesis in the Central Nervous System

中枢神经系统胶质细胞生成和胶质瘤发生的潜在分子机制

基本信息

  • 批准号:
    9536284
  • 负责人:
  • 金额:
    $ 24.06万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2015
  • 资助国家:
    美国
  • 起止时间:
    2015-09-01 至 2020-08-31
  • 项目状态:
    已结题

项目摘要

 DESCRIPTION (provided by applicant): Glia, which constitutes astrocytes and oligodendrocytes, are the most proliferative and abundant cell types in the central nervous system. Abnormal development of astrocytes and oligodendrocytes is associated with a number of neurological diseases and disorders such as amyolateral sclerosis (ALS), multiple sclerosis (MS), autism, epilepsy, schizophrenia, and glioblastoma, the deadliest of brain cancers. The basic-helix-loop-helix (bHLH) transcription factors Ascl1 and Olig2 are crucial for the specification and development of both astrocytes and oligodendrocytes, and are highly expressed in glioblastoma. The proposed project aims to: 1) determine the role and function of Ascl1 and Olig2 in regulating the generation of astrocytes and oligodendrocytes in the gray matter and white matter in the spinal cord; 2) determine the in vivo requirement of Ascl1 and Olig2 in brain tumors of a mouse model of glioblastoma; and 3) utilize Next-Generation sequencing techniques to identify on a genome-wide scale the DNA-binding profiles and direct transcriptional target genes of Ascl1 and Olig2 in glial progenitors in comparison to tumor cells of the glioblastoma mouse model. The culmination of this study will lead to new insights on the genetic regulatory networks of glial heterogeneity and glioblastoma development in the central nervous system.
 描述(由申请人提供):胶质细胞(由星形胶质细胞和少突胶质细胞组成)是中枢神经系统中增殖性最强、数量最多的细胞类型。星形胶质细胞和少突胶质细胞的异常发育与许多神经系统疾病和病症相关,例如肌萎缩侧索硬化症(ALS)、多发性硬化症(MS)、自闭症、癫痫、精神分裂症和胶质母细胞瘤(最致命的脑癌)。碱性螺旋环螺旋(bHLH)转录因子Ascl 1和Olig 2对星形胶质细胞和少突胶质细胞的特化和发育至关重要,并且在胶质母细胞瘤中高度表达。拟议项目旨在:1)确定Ascl 1和Olig 2在调节脊髓中灰质和白色物质中星形胶质细胞和少突胶质细胞的产生中的作用和功能; 2)确定胶质母细胞瘤小鼠模型的脑肿瘤中Ascl 1和Olig 2的体内需求;和3)利用下一代测序技术在全基因组范围内鉴定DNA-与胶质母细胞瘤小鼠模型的肿瘤细胞相比,Ascl 1和Olig 2在胶质祖细胞中的结合谱和直接转录靶基因。这项研究的结果将导致对中枢神经系统胶质异质性和胶质母细胞瘤发展的遗传调控网络的新见解。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Tou Yia Vue其他文献

Tou Yia Vue的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Tou Yia Vue', 18)}}的其他基金

Transcriptional control of OPC fate specification and homing to gray matter and white matter in the CNS
OPC命运规范的转录控制以及中枢神经系统灰质和白质的归巢
  • 批准号:
    10446805
  • 财政年份:
    2022
  • 资助金额:
    $ 24.06万
  • 项目类别:
Transcriptional control of OPC fate specification and homing to gray matter and white matter in the CNS
OPC命运规范的转录控制以及中枢神经系统灰质和白质的归巢
  • 批准号:
    10588159
  • 财政年份:
    2022
  • 资助金额:
    $ 24.06万
  • 项目类别:
Underlying Molecular Mechanisms of Gliogenesis and Gliomagenesis in the Central Nervous System
中枢神经系统胶质细胞生成和胶质瘤发生的潜在分子机制
  • 批准号:
    9126619
  • 财政年份:
    2015
  • 资助金额:
    $ 24.06万
  • 项目类别:
Role of Ascl1 in glioma
Ascl1 在神经胶质瘤中的作用
  • 批准号:
    8634748
  • 财政年份:
    2012
  • 资助金额:
    $ 24.06万
  • 项目类别:
Role of Ascl1 in glioma
Ascl1 在神经胶质瘤中的作用
  • 批准号:
    8317276
  • 财政年份:
    2012
  • 资助金额:
    $ 24.06万
  • 项目类别:
Role of Ascl1 in glioma
Ascl1 在神经胶质瘤中的作用
  • 批准号:
    8448948
  • 财政年份:
    2012
  • 资助金额:
    $ 24.06万
  • 项目类别:

相似海外基金

Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
  • 批准号:
    MR/S03398X/2
  • 财政年份:
    2024
  • 资助金额:
    $ 24.06万
  • 项目类别:
    Fellowship
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
  • 批准号:
    EP/Y001486/1
  • 财政年份:
    2024
  • 资助金额:
    $ 24.06万
  • 项目类别:
    Research Grant
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
  • 批准号:
    2338423
  • 财政年份:
    2024
  • 资助金额:
    $ 24.06万
  • 项目类别:
    Continuing Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
  • 批准号:
    MR/X03657X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 24.06万
  • 项目类别:
    Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
  • 批准号:
    2348066
  • 财政年份:
    2024
  • 资助金额:
    $ 24.06万
  • 项目类别:
    Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
  • 批准号:
    AH/Z505481/1
  • 财政年份:
    2024
  • 资助金额:
    $ 24.06万
  • 项目类别:
    Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10107647
  • 财政年份:
    2024
  • 资助金额:
    $ 24.06万
  • 项目类别:
    EU-Funded
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
  • 批准号:
    2341402
  • 财政年份:
    2024
  • 资助金额:
    $ 24.06万
  • 项目类别:
    Standard Grant
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10106221
  • 财政年份:
    2024
  • 资助金额:
    $ 24.06万
  • 项目类别:
    EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
  • 批准号:
    AH/Z505341/1
  • 财政年份:
    2024
  • 资助金额:
    $ 24.06万
  • 项目类别:
    Research Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了